Literature DB >> 29866692

Headache in an HIV-Positive Patient: Dangerous Interaction.

Alfredo Iardino1, Orlando Garner1, Gabriella Lorusso2, Franco Lotta3.   

Abstract

Ergotism is an ischaemic complication due to vasoconstriction throughout the body due to ingestion of ergotamine. A 34-year-old Hispanic man with HIV infection treated with saquinavir, ritonavir and abacavir/lamivudine presented to the emergency department complaining of left foot pain 1 week prior to admission. The affected extremity was cold with absence of pedal and tibial pulses. Arterial Doppler revealed absent arterial flow from the popliteal artery later confirmed by arteriography. Medication reconciliation revealed a recent prescription for migraine headache containing ergotamine. Drug was discontinued and the patient was started on cilostazol, enoxaparin and nitroglycerin patches on the affected limb. Complete resolution of symptoms and arteriography findings occurred 2 days after therapy began. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drug interactions; drugs and medicines; infections; infectious diseases; interventional cardiology

Mesh:

Substances:

Year:  2018        PMID: 29866692      PMCID: PMC5990057          DOI: 10.1136/bcr-2018-225130

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Transient ischemic attack caused by cerebral ergotism.

Authors:  Gustavo Andrés Gaye-Saavedra; Federico Preve; Silvana Albisu; Mariana Legnani
Journal:  Arq Neuropsiquiatr       Date:  2015-11-24       Impact factor: 1.420

Review 2.  Ergotism: a change of persepective.

Authors:  Javier Eduardo Ferrari Ayarragaray
Journal:  Ann Vasc Surg       Date:  2013-08-28       Impact factor: 1.466

3.  Human immunodeficiency virus post-exposure prophylaxis: primum non nocere.

Authors:  Mikael Alves; Laurène Janneau-Magrino; Nicolas Legendre; Dominique Pateron; Bertrand Guidet; Youri Yordanov
Journal:  Am J Med       Date:  2014-12-05       Impact factor: 4.965

4.  Ergotism Masquerading Systemic Vasculitis.

Authors:  Kanon Jatuworapruk; Thanate Kattipathanapong; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  J Clin Rheumatol       Date:  2017-08       Impact factor: 3.517

Review 5.  Ergotamine in the acute treatment of migraine: a review and European consensus.

Authors:  P Tfelt-Hansen; P R Saxena; C Dahlöf; J Pascual; M Láinez; P Henry; H Diener; J Schoenen; M D Ferrari; P J Goadsby
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

Review 6.  [Drug interactions with antiretroviral agents].

Authors:  V Furlan; A M Taburet
Journal:  Therapie       Date:  2001 May-Jun       Impact factor: 2.070

7.  Clinical ergotism induced by ritonavir.

Authors:  A Vila; A Mykietiuk; P Bonvehì; E Temporiti; A Urueña; F Herrera
Journal:  Scand J Infect Dis       Date:  2001

Review 8.  [Ergotism. A case report and review of the literature].

Authors:  L A Ruano-Calderón; F Zermeño-Pohls
Journal:  Rev Neurol       Date:  2005 Apr 1-15       Impact factor: 0.870

9.  [Ergotism due to simultaneous use of ergot alkaloids and high activity antiretroviral therapy].

Authors:  Daniel Cifuentes M; Sergio Blanco L; Camila Ramírez F
Journal:  Rev Med Chil       Date:  2016-06       Impact factor: 0.553

10.  Ergotism: Case Report and Review of the Literature.

Authors:  Claudia A Liegl; Michael A McGrath
Journal:  Int J Angiol       Date:  2015-02-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.